FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285584138> ?p ?o ?g. }

• W4285584138 endingPage "32" @default.
• W4285584138 startingPage "25" @default.
• W4285584138 abstract "Abstract Objectives To evaluate the serum dosage of the biomedicine (DBM) and the incidence of antidrug antibody (ADA) against antitumor necrosis factor (TNF) in spondyloarthritis, and to demonstrate the influence of these parameters on the clinical efficiency. Methods We conducted a cross-sectional multicentric study including patients with spondylarthritis (SpA) under antiTNF (infliximab [INF], etanercept [ETA] and adalimumab [ADL]) for at least 6 months. A dosage of the ADA and DBM were practiced by the immuno-enzymatic essay. Result Seventy one patients were recruited. Disease modifying antirheumatic drugs (DMARDs) were associated with anti-TNF in 30%. ADA was positive in 54% for INF, 33% for ADL and 0% for ETA with a significant difference(p<0.0001). Immunogenicity was correlated to a bad therapeutic response (Bath Ankylosing Spondylitis Disease Activity Index [BASDAI]≥4)(p=0.04). The DBM was inversely correlated with the rate of ADA for patients treated with INF(p<0.0001) and ADL(p<0.0001). The DBM was also inversely correlated with BASDAI of INF(p=0.03) and ADL (p=0.01). ADA was significantly associated with an anterior switch of anti TNF(p=0.04), the use of INF(p=0.002), presence of coxitis(p=0.01) and higher body mass index (BMI)(p=0.007). DMARDs associated with anti TNF were not a protective factor for positive ADA. In a multivariate study, only INF and BMI were independent factors of positive ADA. Conclusion The ADA formation lowered the DBM and favored the therapeutic failure." @default.
• W4285584138 created "2022-07-16" @default.
• W4285584138 creator A5008429994 @default.
• W4285584138 creator A5016648809 @default.
• W4285584138 creator A5027840398 @default.
• W4285584138 creator A5029834477 @default.
• W4285584138 creator A5033074241 @default.
• W4285584138 creator A5047814535 @default.
• W4285584138 creator A5064818709 @default.
• W4285584138 creator A5077589111 @default.
• W4285584138 creator A5079816098 @default.
• W4285584138 creator A5082394813 @default.
• W4285584138 creator A5087715642 @default.
• W4285584138 date "2020-11-06" @default.
• W4285584138 modified "2023-10-16" @default.
• W4285584138 title "Immunogenicity of antitumor necrosis factor therapy in patients with spondyloarthritis" @default.
• W4285584138 cites W1964924603 @default.
• W4285584138 cites W1975033484 @default.
• W4285584138 cites W1992628263 @default.
• W4285584138 cites W2010442714 @default.
• W4285584138 cites W2019688614 @default.
• W4285584138 cites W2024148297 @default.
• W4285584138 cites W2031785853 @default.
• W4285584138 cites W2052067610 @default.
• W4285584138 cites W2055720024 @default.
• W4285584138 cites W2080876607 @default.
• W4285584138 cites W2110732019 @default.
• W4285584138 cites W2122404129 @default.
• W4285584138 cites W2124551692 @default.
• W4285584138 cites W2125389744 @default.
• W4285584138 cites W2125412490 @default.
• W4285584138 cites W2133606090 @default.
• W4285584138 cites W2138572955 @default.
• W4285584138 cites W2141395406 @default.
• W4285584138 cites W2145778588 @default.
• W4285584138 cites W2149065814 @default.
• W4285584138 cites W2149168537 @default.
• W4285584138 cites W2307567353 @default.
• W4285584138 cites W2313469486 @default.
• W4285584138 cites W2328587823 @default.
• W4285584138 cites W2411383404 @default.
• W4285584138 cites W2591808642 @default.
• W4285584138 cites W2739549941 @default.
• W4285584138 cites W2791241075 @default.
• W4285584138 cites W2791600277 @default.
• W4285584138 cites W2924583065 @default.
• W4285584138 doi "https://doi.org/10.1515/dmpt-2020-0139" @default.
• W4285584138 hasPublicationYear "2020" @default.
• W4285584138 type Work @default.
• W4285584138 citedByCount "0" @default.
• W4285584138 crossrefType "journal-article" @default.
• W4285584138 hasAuthorship W4285584138A5008429994 @default.
• W4285584138 hasAuthorship W4285584138A5016648809 @default.
• W4285584138 hasAuthorship W4285584138A5027840398 @default.
• W4285584138 hasAuthorship W4285584138A5029834477 @default.
• W4285584138 hasAuthorship W4285584138A5033074241 @default.
• W4285584138 hasAuthorship W4285584138A5047814535 @default.
• W4285584138 hasAuthorship W4285584138A5064818709 @default.
• W4285584138 hasAuthorship W4285584138A5077589111 @default.
• W4285584138 hasAuthorship W4285584138A5079816098 @default.
• W4285584138 hasAuthorship W4285584138A5082394813 @default.
• W4285584138 hasAuthorship W4285584138A5087715642 @default.
• W4285584138 hasConcept C102652120 @default.
• W4285584138 hasConcept C120665830 @default.
• W4285584138 hasConcept C121332964 @default.
• W4285584138 hasConcept C126322002 @default.
• W4285584138 hasConcept C141071460 @default.
• W4285584138 hasConcept C159654299 @default.
• W4285584138 hasConcept C17991360 @default.
• W4285584138 hasConcept C203014093 @default.
• W4285584138 hasConcept C2776260265 @default.
• W4285584138 hasConcept C2777138892 @default.
• W4285584138 hasConcept C2777226972 @default.
• W4285584138 hasConcept C2777402515 @default.
• W4285584138 hasConcept C2777453003 @default.
• W4285584138 hasConcept C2779134260 @default.
• W4285584138 hasConcept C2780132546 @default.
• W4285584138 hasConcept C2780221984 @default.
• W4285584138 hasConcept C2780415856 @default.
• W4285584138 hasConcept C2780868878 @default.
• W4285584138 hasConcept C61511704 @default.
• W4285584138 hasConcept C71924100 @default.
• W4285584138 hasConcept C90924648 @default.
• W4285584138 hasConceptScore W4285584138C102652120 @default.
• W4285584138 hasConceptScore W4285584138C120665830 @default.
• W4285584138 hasConceptScore W4285584138C121332964 @default.
• W4285584138 hasConceptScore W4285584138C126322002 @default.
• W4285584138 hasConceptScore W4285584138C141071460 @default.
• W4285584138 hasConceptScore W4285584138C159654299 @default.
• W4285584138 hasConceptScore W4285584138C17991360 @default.
• W4285584138 hasConceptScore W4285584138C203014093 @default.
• W4285584138 hasConceptScore W4285584138C2776260265 @default.
• W4285584138 hasConceptScore W4285584138C2777138892 @default.
• W4285584138 hasConceptScore W4285584138C2777226972 @default.
• W4285584138 hasConceptScore W4285584138C2777402515 @default.
• W4285584138 hasConceptScore W4285584138C2777453003 @default.
• W4285584138 hasConceptScore W4285584138C2779134260 @default.
• W4285584138 hasConceptScore W4285584138C2780132546 @default.

• next